CardioSignal Inc strengthens expertise in AgeTech and joins AgeTech Collaborative™ from AARP®
To break barriers in the scalability and accessibility of remote cardiac care technology among older adults, CardioSignal has become a portfolio company of AgeTech Collaborative™ from AARP® after completing its prestigious accelerator program. Joining the network will help gain key market insights and build growth in the rapidly growing AgeTech market.
The CardioSignal technology aims to make earlier detection of heart diseases more accessible to people through their smartphones. In the hands of older adults and caregivers, a smartphone-based strategy has significant potential to provide preventative cardiovascular care, enabling older adults to lead healthier lives in their homes for longer.
“We see tremendous value in offering this technology as a population health strategy for older adults. Using a smartphone as a measuring device removes a key barrier in adopting and adhering to a regular monitoring routine and does not require any additional devices. In our annual user surveys, 93% of people above 60 have found our technology very easy to use,” states Tero-Pekka Alastalo (MD, PhD), President of CardioSignal Inc.
According to AARP, as much as 68% of people 50-plus do not think technology is designed with their age group in mind. However, this population is expected to spend $120.2 billion on technology annually in 2030 (1). The average American spends roughly 5 hours a day on their phone (2).
“Smartphones are everywhere. The future of care delivery means reorienting healthcare where the users are. For care delivery, the smartphone ecosystem offers unparalleled opportunities for engagement, efficiency, and better access to care,” Alastalo sums up.
The share of Americans that own a smartphone is 85%. Smartphone ownership has exploded in the 65+ age group over the past decade and now stands at 61%, nearly five times more than in 2012 (3-4).
The CardioSignal technology utilizes the sensitive motion sensors of a smartphone to measure cardiac motion when the smartphone is placed on the chest for one minute. In clinical studies, this method, gyrocardiography, has been found effective for detecting signs of heart disease, such as atrial fibrillation and heart failure. Removing the need for additional devices enables unlimited scalability to advance earlier detection among the growing number of individuals with cardiovascular disease factors.
Further information:
President Tero-Pekka Alastalo, CardioSignal Inc, tpa@cardiosignal.com. tel. +1 (650) 285-8564
Communication Director Juulia Simonen, juulia.simonen@cardiosignal.com, tel. (+358) 503059018
About AgeTech Collaborative™ from AARP®:
AgeTech Collaborative™ from AARP® is an unparalleled innovation ecosystem bringing together cutting-edge thinkers in the longevity tech space to champion meaningful advances so that everyone can choose how they live as they age. AARP’s decades of exclusive longevity insights, the breakthrough collaborative ecosystem and community of innovators positions the AgeTech Collaborative to lead the future of AgeTech. https://agetechcollaborative.org/
About CardioSignal
We develop groundbreaking solutions for the detection of heart diseases with digital cardiac biomarkers. The CardioSignal technology utilizes motion sensors to non-invasively measure chest movements and determine cardiac motion and function. Originally an academic spinoff, the company’s patented technology is built on a decade of research and algorithm development. CardioSignal Inc is a subsidiary of the Finnish health technology company Precordior ltd. cardiosignal.com / us.cardiosignal.com.
Sources:
1. 2023 Tech Trends and the 50-Plus. Washington, DC: AARP Research, January 2023.
2. Statista: Average time spent daily on a smartphone in the United States 2021
3. Pew research, Mobile Fact Sheet 2021
4. Pew Research, 2022, Share of Tech Users among Older Americans
